Efficacy of sorafenib in the treatment of radioactive iodine-refractory differentiated thyroid cancer and corresponding effects on serum Tg and TgAb

LUO Liyuan; DONG Peng; CHEN Jie

doi:10.3969/j.issn.1002-7386.2022.20.016

Home>Articles>Efficacy of sorafenib in the treatment of radioactive iodine-refractory differentiated thyroid cancer and corresponding effects on serum Tg and TgAb

DOI: 10.3969/j.issn.1002-7386.2022.20.016

Efficacy of sorafenib in the treatment of radioactive iodine-refractory differentiated thyroid cancer and corresponding effects on serum Tg and TgAb

LUO Liyuan

DONG Peng

CHEN Jie

Machine-generated Keywords：

Publication Date：2022-10-25

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 3110-3113 )

Hebei Medical Journal

ISTIC

ISSN：1002-7386

Year, Vol.(Issue)：2022,44(20)